Nuala Calnan and Rob de la Espriella investigate how BioPharma can learn ways to prevent recurring events and ineffective CAPA from the nuclear power sector.
Getting to the Root of the Matter for BioPharma Quality Issues
top of page
bottom of page
Nuala Calnan and Rob de la Espriella investigate how BioPharma can learn ways to prevent recurring events and ineffective CAPA from the nuclear power sector.
Comments